New York Life Investment Management’s IQ US Large Cap R&D Leaders ETF LRND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $379M | Buy |
8,599,898
+3,180,497
| +59% | +$136M | 2.65% | 4 |
|
|
2026
Q1 | $201M | Buy |
5,419,401
+3,814,585
| +238% | +$151M | 1.7% | 10 |
|
|
2025
Q4 | $65.4M | Buy |
1,604,816
+1,414,816
| +745% | +$57.3M | 0.56% | 32 |
|
|
2025
Q3 | $7.56M | Hold |
190,000
| – | – | 0.07% | 254 |
|
|
2025
Q2 | $6.86M | Hold |
190,000
| – | – | 0.06% | 258 |
|
|
2025
Q1 | $6.11M | Hold |
190,000
| – | – | 0.06% | 278 |
|
|
2024
Q4 | $6.49M | Hold |
190,000
| – | – | 0.06% | 264 |
|
|
2024
Q3 | $6.33M | Hold |
190,000
| – | – | 0.06% | 283 |
|
|
2024
Q2 | $6.22M | Hold |
190,000
| – | – | 0.06% | 273 |
|
|
2024
Q1 | $5.98M | Hold |
190,000
| – | – | 0.06% | 289 |
|
|
2023
Q4 | $5.38M | Hold |
190,000
| – | – | 0.06% | 306 |
|
|
2023
Q3 | $4.77M | Hold |
190,000
| – | – | 0.05% | 315 |
|
|
2023
Q2 | $4.89M | Hold |
190,000
| – | – | 0.05% | 315 |
|
|
2023
Q1 | $4.36M | Hold |
190,000
| – | – | 0.05% | 343 |
|
|
2022
Q4 | $3.79M | Hold |
190,000
| – | – | 0.04% | 383 |
|
|
2022
Q3 | $3.65M | Hold |
190,000
| – | – | 0.04% | 371 |
|
|
2022
Q2 | $190K | Hold |
190,000
| – | – | ﹤0.01% | 1233 |
|
|
2022
Q1 | $4.78M | Buy |
+190,000
| New | +$4.63M | 0.25% | 29 |
|
New York Life Investment Management's LRND Position: Q2 2026 in Review
New York Life Investment Management increased its IQ US Large Cap R&D Leaders ETF (LRND) stake by 59% in Q2 2026, buying an estimated $136M and bringing the position to 8,599,898 shares worth $379M. The position accounts for 2.65% of the portfolio, ranked #4.
New York Life Investment Management first reported a position in LRND in Q1 2022 and has held it in 18 quarters since. 1 fund tracked by Wall St. Rank holds LRND as of Q2 2026.
- New York Life Investment Management held 8,599,898 shares of IQ US Large Cap R&D Leaders ETF worth $379M as of Q2 2026.
- New York Life Investment Management bought 3,180,497 IQ US Large Cap R&D Leaders ETF shares in Q2 2026, an estimated $136M.
- IQ US Large Cap R&D Leaders ETF made up 2.65% of New York Life Investment Management's portfolio in Q2 2026, its #4 holding.
- New York Life Investment Management first reported a position in IQ US Large Cap R&D Leaders ETF in Q1 2022 and has held it in 18 quarters since.
- 1 fund tracked by Wall St. Rank held IQ US Large Cap R&D Leaders ETF as of Q2 2026.
Based on New York Life Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.